SCHEMBL3825450

SCHEMBL3825450

NCc1nnc(-c2ccc(C(F)(F)F)cc2)o1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 2/20 0.62
▸ NPC1 O15118 3/20 0.51
▸ KDM4E B2RXH2 4/20 0.50
▸ POLB P06746 2/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ GSK3B P49841 2/20 0.49
▸ USP2 O75604 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ SUCNR1 Q9BXA5 1/20 0.48
▸ RAB9A P51151 3/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.47
▸ HPGD P15428 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ QPCT Q16769 1/20 0.46
▸ BCHE P06276 2/20 0.44
▸ ACHE P22303 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3828382 0.90 NOTUM (0.55) NOTUMNPC1KDM4EPOLBALDH1A1
SCHEMBL21590146 0.83 NPC1 (0.51) NOTUMNPC1KDM4EPOLBALDH1A1
SCHEMBL5901252 0.83 ALDH1A1 (0.62) NOTUMNPC1KDM4EPOLBALDH1A1
SCHEMBL13899158 0.83 NOTUM (0.62) NOTUMNPC1KDM4EPOLBALDH1A1
SCHEMBL18528795 0.82 NPC1 (0.69) NOTUMNPC1KDM4EPOLBALDH1A1
SCHEMBL2093817 0.80 RAB9A (0.53) NOTUMNPC1KDM4EPOLBALDH1A1
SCHEMBL5754354 0.79 KDM4E (0.71) NOTUMNPC1KDM4EPOLBALDH1A1
SCHEMBL6605684 0.78 NPC1 (0.47) NOTUMNPC1KDM4EPOLBALDH1A1
SCHEMBL6605688 0.78 NR1H4 (0.52) NOTUMNPC1KDM4EPOLBALDH1A1
SCHEMBL3823171 0.77 NOTUM (0.68) NOTUMNPC1KDM4EPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 — — EP claimed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 — — US claimed
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 — — EP disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 — — US disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 — — US disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF PYGL, GYS2, G6PC1 NOTUM 298/4885NPC1 2552/4885KDM4E 1955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback